What is eddii?
eddii is a digital health company dedicated to providing comprehensive diabetes and endocrine care through an innovative application. The platform empowers users to manage their health effectively, integrate with devices like Dexcom CGM, and access virtual consultations with endocrinologists for conditions including diabetes, weight management, PCOS, and thyroid disorders. By combining daily health tracking with expert virtual care, eddii offers a convenient and accessible solution for individuals managing chronic endocrine conditions. The company's user-friendly interface aims to enhance patient engagement and streamline health management, positioning it as a key player in the digital therapeutics space.
How much funding has eddii raised?
eddii has raised a total of $2.5M across 1 funding round:
Angel/Seed
$2.5M
Angel/Seed (2023): $2.5M with participation from Atento Capital, StartUp Health, and Kapor Capital
Key Investors in eddii
Atento Capital
Atento Capital is a venture capital firm based in Tulsa, focused on supporting early-stage founders by providing financial, human, and social capital. They are known for their commitment to fostering entrepreneurial ecosystems and connecting founders with essential resources.
StartUp Health
StartUp Health is a global entity investing in health innovation companies, aiming to transform healthcare delivery and outcomes. They have a broad portfolio and focus on companies working towards significant health advancements.
Kapor Capital
Kapor Capital is an investment firm that focuses on supporting entrepreneurs from underrepresented communities and building companies that create positive social impact. Their investments often target technology solutions addressing societal needs.
What's next for eddii?
With the recent infusion of major strategic investment, eddii is poised for significant expansion and enhancement of its service offerings. The company is likely to focus on scaling its user base, further integrating advanced health monitoring technologies, and potentially broadening its scope of specialized endocrine care. This capital injection will also support ongoing research and development to refine its app's capabilities and ensure it remains at the forefront of digital health solutions for diabetes and related conditions. Strategic partnerships and continued innovation will be critical as eddii aims to solidify its market position and improve health outcomes for a growing number of patients.
See full eddii company page
